Literature DB >> 16480397

A survey of oesophageal cancer: pathology, stage and clinical presentation.

B Schlansky1, A J Dimarino, D Loren, A Infantolino, T Kowalski, S Cohen.   

Abstract

BACKGROUND: Oesophageal adenocarcinoma is the sixth leading cause of cancer-related mortality worldwide. Previously, oesophageal cancer was mainly squamous cell, presenting late with dysphagia and weight loss. AIMS: To examine the distribution of oesophageal cancer histopathology at a large, urban hospital; to determine the tumour stage and symptoms at presentation; and to evaluate the impact of endoscopic surveillance in Barrett's oesophagus.
METHODS: From 1999 to 2004, all patients diagnosed with oesophageal cancer were evaluated retrospectively for demographics and tumour stage at presentation using endoscopic ultrasonography and computerized tomography.
RESULTS: A total of 131 patients were included. 81% of tumours were adenocarcinomas; most localized to the distal oesophagus (97%). Patients presented with dysphagia (56%), pain (30%) and/or weight loss (16%). Irrespective of histology, locally advanced lesions accounted for most cases. Thirteen patients had lesions detected in Barrett's surveillance; these were early or intermediate stage in nine patients, but late stage in four patients.
CONCLUSIONS: Adenocarcinoma has become the dominant histologic subtype, comprising 81% of proven malignancies. Despite a change in histopathology, most cancers are diagnosed at an advanced stage, presenting with dysphagia, pain and/or weight loss. Endoscopic surveillance of Barrett's oesophagus allows earlier diagnosis of cancer in most, but not all, patients.

Entities:  

Mesh:

Year:  2006        PMID: 16480397     DOI: 10.1111/j.1365-2036.2006.02782.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  18 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Esophageal squamous cell carcinoma - precursor lesions and early diagnosis.

Authors:  Antonio Barros Lopes; Renato Borges Fagundes
Journal:  World J Gastrointest Endosc       Date:  2012-01-16

3.  Chemoprevention of esophageal adenocarcinoma.

Authors:  Julian A Abrams
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

4.  Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.

Authors:  Tara R Semenkovich; Roheena Z Panni; Jessica L Hudson; Theodore Thomas; Leisha C Elmore; Su-Hsin Chang; Bryan F Meyers; Benjamin D Kozower; Varun Puri
Journal:  J Thorac Cardiovasc Surg       Date:  2018-01-12       Impact factor: 5.209

5.  Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma.

Authors:  Matthew Egyud; Mohamedtaki Tejani; Arjun Pennathur; James Luketich; Praveen Sridhar; Emiko Yamada; Anders Ståhlberg; Stefan Filges; Paul Krzyzanowski; Jennifer Jackson; Irina Kalatskaya; Wei Jiao; Gradon Nielsen; Zhongren Zhou; Virginia Litle; Lincoln Stein; Tony Godfrey
Journal:  Ann Thorac Surg       Date:  2019-05-03       Impact factor: 4.330

Review 6.  Predictive biomarkers for Barrett's esophagus: so near and yet so far.

Authors:  M R Timmer; G Sun; E C Gorospe; C L Leggett; L Lutzke; K K Krishnadath; K K Wang
Journal:  Dis Esophagus       Date:  2013-01-14       Impact factor: 3.429

7.  ENDOSCOPIC TREATMENT OF ESOPHAGEAL NEOPLASIA: A DECADE OF EVOLUTION.

Authors:  Nicholas J Shaheen
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

8.  Increased p53 expression in the malignant transformation of Barrett's esophagus is accompanied by an upward shift of the proliferative compartment.

Authors:  Istvan Hritz; Hajnalka Gyorffy; Bela Molnar; Gabor Lakatos; Ferenc Sipos; Istvan Pregun; Mark Juhasz; Laszlo Pronai; Zsuzsa Schaff; Zsolt Tulassay; Laszlo Herszenyi
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

Review 9.  Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.

Authors:  Chin-Ann J Ong; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

10.  Recurring Translocations in Barrett's Esophageal Adenocarcinoma.

Authors:  Manisha Bajpai; Anshuman Panda; Kristen Birudaraju; James Van Gurp; Amitabh Chak; Kiron M Das; Parisa Javidian; Hana Aviv
Journal:  Front Genet       Date:  2021-06-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.